XIAOJING WANG, LAC
Acupuncture at Telegraph Ave, Oakland, CA
License number
California 16793
Category
Acupuncture
Type
Acupuncturist
Address
Address
6613 Telegraph Ave, Oakland, CA 94609
Phone
(510) 847-7501
Personal information
See more information about XIAOJING WANG at radaris.comName
Address
Phone
108 N Moore Ave APT A, Monterey Park, CA 91754
166 Oxford St, Hercules, CA 94547
2429 Sacramento St, Berkeley, CA 94702
3060 Chateau Way, Livermore, CA 94550
931 E Walnut St UNIT 206, Pasadena, CA 91106
Professional information
Xiaojing Wang
Location:
Oakland, California
Industry:
Health, Wellness and Fitness
Skills:
Policy Analysis, Non-profits, Community Outreach, Public Policy, Editing, Research, Nonprofits, Training
Quinazolines For Pdk1 Inhibition
US Patent:
2010021, Aug 26, 2010
Filed:
Dec 20, 2007
Appl. No.:
12/448390
Inventors:
Mina Aikawa - Emeryville CA, US
Payman Amiri - Emeryville CA, US
Steven Bashman - Emeryville CA, US
Jeffrey Dove - Emeryville CA, US
Rama Jain - Emeryville CA, US
Xiaodong Lin - Emeryville CA, US
Jeremy Murray - Emeryville CA, US
Savithri Ramurthy - Emeryville CA, US
Alice Rico - Emeryville CA, US
Wei Shu - Emeryville CA, US
Sharadha Subramanian - Emeryville CA, US
Xiaojing Michael Wang - Emeryville CA, US
Robert L. Warne - Emeryville CA, US
Yasheen Zhou - Emeryville CA, US
Payman Amiri - Emeryville CA, US
Steven Bashman - Emeryville CA, US
Jeffrey Dove - Emeryville CA, US
Rama Jain - Emeryville CA, US
Xiaodong Lin - Emeryville CA, US
Jeremy Murray - Emeryville CA, US
Savithri Ramurthy - Emeryville CA, US
Alice Rico - Emeryville CA, US
Wei Shu - Emeryville CA, US
Sharadha Subramanian - Emeryville CA, US
Xiaojing Michael Wang - Emeryville CA, US
Robert L. Warne - Emeryville CA, US
Yasheen Zhou - Emeryville CA, US
International Classification:
A61K 31/337, C07D 239/84, A61K 31/517, C07D 401/12, A61K 31/496, C07D 403/10, C07D 413/10, A61K 31/5377, C07D 413/14, C07D 403/12, A61P 35/00
US Classification:
51421021, 544292, 5142664, 544284, 51426621, 51425217, 544359, 544122, 5142345, 5142325, 544 80, 548952
Abstract:
The invention provides novel compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
Imidazoquinoline Compounds
US Patent:
2008021, Sep 4, 2008
Filed:
Sep 14, 2005
Appl. No.:
11/662984
Inventors:
Nicholas Valiante - Emeryville CA, US
Feng Xu - Emeryville CA, US
Xiaodong Lin - Emeryville CA, US
Daniel Chu - Santa Clara CA, US
Xiaojing Michael Wang - Emeryville CA, US
Feng Xu - Emeryville CA, US
Xiaodong Lin - Emeryville CA, US
Daniel Chu - Santa Clara CA, US
Xiaojing Michael Wang - Emeryville CA, US
International Classification:
C07D 471/04, A61K 31/437, A61K 39/02, A61K 39/12, A61K 39/145, A61K 39/245, A61K 39/29, A61P 31/12
US Classification:
4242081, 546 82, 514293, 51421021, 4242041, 4242341, 4242281, 4242091
Abstract:
The invention provides novel compositions comprising imidazoquinoline compounds. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an)other agent(s).